FDA Inspection 1031414 — Seattle Reproductive Medicine, Inc., P.S.
The FDA completed an inspection of Seattle Reproductive Medicine, Inc., P.S. on Oct 24, 2017 in Bellevue, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 24, 2017
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Bellevue, WA (United States)